Auxilium rejects ‘significantly undervalued’ Endo takeover
Endo International’s bid to acquire Auxilium Pharmaceuticals last week has been rejected by the latter, according to news agency Reuters. Auxilium is said to have made the statement that the bid “significantly undervalues” the company. more »
Sep 22, 2014 2:58 PM News
Ex-Retrophin CEO launches new drug company
A new company, Turing Pharmaceuticals, launched this week, headed by the former CEO of Retrophin. more »
Feb 25, 2015 1:45 PM News
SGS adds to biomarker analysis service
SGS Life Science Services, a clinical and bioanalytical contract group has invested in additional modules for its COBAS 6000 analysis system, to increase its biomarker analytical capabilities. more »
Feb 25, 2015 12:01 PM News
Smart syringes must be mainstream by 2020, says WHO
In its latest push to tackle unsafe injection, the World Health Organization (WHO) has launched a new campaign to drive the use of 'smart' syringes. more »
Feb 24, 2015 11:11 AM News
Internet of things to lower the labelling risk
A new connected labelling platform may help reduce regulatory risk for device and drug manufacturers. more »
Feb 23, 2015 10:58 AM News
Parexel to offer faster enrolment for clinical trial patients
Expansions to its site alliance network mean biopharma specialist will be able to offer clients faster enrolment times for clinical trials. more »
Feb 23, 2015 9:12 AM News
Press&Take dosage system scoops fourth innovation award
Medical device manufacturer Stiplastics received the Best Innovation award for Press&Take, a product designed for the dosage of granules, micro tablets and capsules. more »
Feb 18, 2015 9:52 AM Technology
GEA and Freeman test continuous tablet manufacture
A collaborative research project between Freeman Technology and GEA Pharma Systems is progressing the development of continuous tablet manufacturing. more »
Feb 16, 2015 12:01 PM Technology
Is Real World Evidence replacing clinical trials?
Wearables, sensors, mobile health and social media are all set to have an impact on the pharma sector. New studies look at the extent of the more »
Feb 13, 2015 1:44 PM Opinion
MHRA brings Japanese pharma group to Europe
The Medicines and Healthcare products Regulatory Agency (MHRA) has helped Eisai, a Japanese pharmaceutical company, to develop its first European site. more »
Jan 30, 2015 9:24 AM News
Cell cultures - in 3D
Bioneer, a Danish Biotech group, has devised a method to enable 3D cell culture growth. more »
Jan 28, 2015 11:51 AM Technology
GCS caps commitment to closures
Global Closure Systems will bring its latest portfolio of child resistant and tamper evident closures to Pharmapack Europe, exhibiting on stand 536. more »
Jan 26, 2015 3:09 PM Technology
Life Sciences Minister on DNA and data
George Freeman MP, the Minister for Life Sciences, will give a keynote address for the pharma sector at an event which will tackle the future of DNA and data in healthcare. more »
Jan 26, 2015 11:00 AM News
Achema promises "shake up" for the process sector
Over 3,100 exhibitors have signed up for Achema, and,the organisers anticipate around 3,800 by the time doors open on 15th June. more »
Jan 23, 2015 2:35 PM News
Catalent upgrades Eberbach, adding more softgels
Catalent's latest round of upgrades will expand on its ranges of softgels. more »
Jan 23, 2015 9:09 AM Technology
Big growth for drug/device combinations
The global drug/device combination products market is expected to witness significant growth in the years to come. more »
Jan 20, 2015 11:34 AM News
Domino Printing enters technology partnership with Omron
Coding and marking specialist Domino Printing Sciences has joined forces with vision and automation business Omron. more »
Jan 13, 2015 11:56 AM Technology
NHS "fundamentally flawed" says Sanofi amid cancer drugs cuts
Sanofi has spoken out about recent cuts to the UK's Cancer Drugs Fund, which will see at least two of its drugs delisted from March 12th. more »
Jan 13, 2015 10:11 AM News
Shire to acquire NPS Pharma in gastrointestinal and rare disease knowledge-share
Shire is to acquire all outstanding shares of NPS Pharmaceuticals for $46.00 per share in cash, for a total consideration of approximately $5.2 billion. more »
Jan 12, 2015 11:47 AM News
MGB Biopharma talks anti-infectives for antibiotic resistance
MGB Biopharma, a biopharmaceutical company developing a new class of anti-infectives, provides an update on its performance for 2014. more »
Jan 12, 2015 9:40 AM News
Catalent appoints general managers for clinical supply services
Catalent Pharma Solutions has appointed two General Managers to oversee key Clinical Supply Services facilities in its European network. more »
Jan 8, 2015 1:06 PM News